Your browser doesn't support javascript.
loading
Aspirina ¿No más para prevención primaria? / No more aspirine for primary prevention
Arocha Rodulfo, José Ildefonzo.
  • Arocha Rodulfo, José Ildefonzo; Sociedad Venezolana de Cardiología. Caracas. VE
Med. interna (Caracas) ; 35(1): 3-9, 2019.
Article in Spanish | LILACS, LIVECS | ID: biblio-1000244
RESUMEN
El uso de dosis baja de aspirina en prevención primaria de eventos cardiovasculares (CV) en sujetos sanos o aparentemente sanos es un tópico ampliamente debatido. Muchos argumentos indican que la "prevención primaria" es solo una definición convencional y que la transición a la prevención secundaria representa un continuo de elevación de valores del riesgo CV. Aunque no hay pruebas consistentes de la eficacia de la aspirina en diferentes niveles de riesgo CV, en las poblaciones de riesgo bajo parece ser menos eficiente. Esta revisión de los tres nuevos estudios aleatorios señalan que tanto los adultos aparentemente sanos y los pacientes con diabetes obtienen muy poco beneficio protector de la aspirina considerando el incremento en el riesgo de eventos de sangrado severo.(AU)
ABSTRACT
The use of low-dose aspirin in primary prevention of cardiovascular (CV) events in healthy or apparently healthy people is a widely debated topic. Many arguments indicate that "primary prevention" is only a conventional definition and that the transition from primary to secondary prevention represents a continuum of increasing levels of CV risk. Although there are no consistent proofs of efficacy of aspirin at different CV risk levels, in low-risk population aspirin appear to be less efficient. This review of three new randomized trials indicated that both the apparently healthy adults and patients with diabetes would derive little protective benefit from aspirin considering the increased risk of severe bleeding events(AU)
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Blood Coagulation / Coronary Thrombosis / Aspirin / Diabetes Mellitus Type of study: Controlled clinical trial Limits: Aged / Aged80 / Female / Humans / Male Language: Spanish Journal: Med. interna (Caracas) Journal subject: Glƒndulas End¢crinas / Horm“nios / Internal Medicine Year: 2019 Type: Article Affiliation country: Venezuela Institution/Affiliation country: Sociedad Venezolana de Cardiología/VE

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Blood Coagulation / Coronary Thrombosis / Aspirin / Diabetes Mellitus Type of study: Controlled clinical trial Limits: Aged / Aged80 / Female / Humans / Male Language: Spanish Journal: Med. interna (Caracas) Journal subject: Glƒndulas End¢crinas / Horm“nios / Internal Medicine Year: 2019 Type: Article Affiliation country: Venezuela Institution/Affiliation country: Sociedad Venezolana de Cardiología/VE